Puma Biotechnology
Biotechnology
Overview
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care.
Jobs
$140k – $165k per year · Hybrid · Full-Time · 5+ years exp · Bachelor's Degree · Los Angeles
GCP
Life Sciences
Good Clinical Practice
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$210k
Typical range
$165k – $235k
Open positions
5
5
Jobs
Senior
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 5 | $210k | $165k – $235k |
Highest paying role
Strategic Account Manager - North Central Region
$235k
Normalized to USD per year
All salaries at Puma Biotechnology
By role, level and city, against the market · 5 jobs with pay
Visa sponsorship
4
H-1B filings in 12 months
$158k
Median offered salary
5
Open roles in United States
Who they sponsor
Industrial production managers
4
In the register as Puma Biotechnology, Inc, Los Angeles, CA
Other sponsors in the same field
Daiichi Sankyo 
Dechert 
Kashiv Biosciences 
Avaya
See 5 open roles Alert me
US Department of Labor · latest filing Jun 22, 2026 · Visa details by country
Growth
Hiring Momentum
24/100
Hiring freeze
Open positions
5
0 opened / 0 closed in 30 days
Median time-to-fill
50 days
faster than 27% of the market
ATS activity
Every ~6 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
67% ▼
Marketing
17% ▲
Biotech
17% ▲
Tech stack
Technologies named in job postings at Puma Biotechnology over the last 12 months, by layer, with the share of postings for each.
Technologies in use
2
Postings analysed
1
Stack modernity
53/100
Cloud & platforms
GCP
Practices & domains
Good Clinical Practice
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Foresite CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Puma Biotechnology Initiates ALISCA-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
Read more
Report
Puma Biotechnology to Present at H.C. Wainwright's 28th Annual Global Investment Conference
LOS ANGELES, September 09, 2026--On Sept. 14, 2026, Puma Biotechnology CEO Alan Auerbach will present a corporate overview at H.C. Wainwright
Read more
Report
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - August 5, 2026
Read more
Report
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results
LOS ANGELES, July 23, 2026--Puma Biotechnology will host a conference call at 1:30 p.m. PT on August 6, 2026, following release of its 2Q-2026 results.
Read more
Report
Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer at the ESMO Congress 2022
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Los Angeles
Los Angeles
United States
2 open roles 2 posted in 90 days 50% remote $188k Avg Salary
hires for Sales, Biotech